DataHow AG is a Switzerland-based startup that is making waves in the bioprocessing industry with its innovative approach to leveraging artificial intelligence. The company's slogan "Tranforming Bioprocessing with AI" encapsulates its mission to revolutionize bioprocess development and optimization. Founded in 2017, DataHow AG has established itself as a leader in the convergence of automation, biotechnology, and manufacturing. Embedded with extensive bioprocess expertise and cutting-edge technologies, DataHow AG's software solutions address the specific challenges of bioprocesses, offering support through data pre-processing, process model development, and the generation of rich process insights. The structured workflows and cloud-based infrastructure facilitate the seamless generation and sharing of process insights across organizations, setting a new standard for efficiency and collaboration in the biopharma industry. Moreover, DataHow AG has garnered significant attention and investment, with its most recent Series A investment secured on 28 May 2024. Notably, the investors in this round included Momenta Partners, Rockwell Automation, and Zürcher Kantonal Bank, underscoring the confidence and interest from notable players in the industry. The company's website provides further insight into its services and products, establishing a channel for engagement and information dissemination. With a strong track record of transforming bioprocess development for major biopharma companies, DataHow AG is poised to play a pivotal role in ushering in the era of industry 4.0 in biopharma. As the company continues to evolve and expand its influence, its innovative technologies are set to reshape the landscape of bioprocessing, cementing its position as a trailblazer in the intersection of AI and biotechnology.
No recent news or press coverage available for DataHow AG.